Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilaria Giunzioni

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Vascular Health and Risk Management|September 9, 2015
New developments in atherosclerosis: clinical potential of PCSK9 inhibitionIlaria Giunzioni, Hagai Tavori
Current Opinion in Endocrinology, Diabetes, and Obesity|February 19, 2015
PCSK9 inhibition to reduce cardiovascular disease risk: recent findings from the biology of PCSK9Hagai Tavori, Ilaria Giunzioni, Sergio Fazio
Circulation Research|June 22, 2014
Response to Duell et alHagai Tavori, Ilaria Giunzioni, MacRae F Linton, et al.
Circulation Research|October 15, 2013
Loss of plasma proprotein convertase subtilisin/kexin 9 (PCSK9) after lipoprotein apheresisHagai Tavori, Ilaria Giunzioni, MacRae F Linton, et al.
Circulation|May 6, 2015
Response to letter regarding article, "Proprotein convertase subtilisin kexin type 9 promotes intestinal overproduction of triglyceride-rich apolipoprotein B lipoproteins through both low-density lipoprotein receptor-dependent and -independent mechanisms"Shirya Rashid, Hagai Tavori, Patrick E Brown, et al.
Journal of Lipid Research|September 4, 2014
Macrophage-derived apoESendai suppresses atherosclerosis while causing lipoprotein glomerulopathy in hyperlipidemic miceHagai Tavori, Daping Fan, Ilaria Giunzioni, et al.
Circulation|July 30, 2014
Proprotein convertase subtilisin kexin type 9 promotes intestinal overproduction of triglyceride-rich apolipoprotein B lipoproteins through both low-density lipoprotein receptor-dependent and -independent mechanismsShirya Rashid, Hagai Tavori, Patrick E Brown, et al.
Circulation|May 26, 2018
Deletion of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Accelerates Atherosclerosis Regression and Increases C-C Chemokine Receptor Type 7 (CCR7) Expression in Plaque MacrophagesPaul A Mueller, Lin Zhu, Hagai Tavori, et al.
Circulation|April 16, 2019
Response by Mueller et al to Letter Regarding Article, "Deletion of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Accelerates Atherosclerosis Regression and Increases C-C Chemokine Receptor Type 7 (CCR7) Expression in Plaque Macrophages"Paul A Mueller, Lin Zhu, Hagai Tavori, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 2, 2016
Loss of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 Confers Resistance to the Antiatherogenic Effects of Tumor Necrosis Factor-α InhibitionLin Zhu, Ilaria Giunzioni, Hagai Tavori, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Vascular Health and Risk Management|September 9, 2015
New developments in atherosclerosis: clinical potential of PCSK9 inhibitionIlaria Giunzioni, Hagai Tavori
Current Opinion in Endocrinology, Diabetes, and Obesity|February 19, 2015
PCSK9 inhibition to reduce cardiovascular disease risk: recent findings from the biology of PCSK9Hagai Tavori, Ilaria Giunzioni, Sergio Fazio
Circulation Research|June 22, 2014
Response to Duell et alHagai Tavori, Ilaria Giunzioni, MacRae F Linton, et al.
Circulation Research|October 15, 2013
Loss of plasma proprotein convertase subtilisin/kexin 9 (PCSK9) after lipoprotein apheresisHagai Tavori, Ilaria Giunzioni, MacRae F Linton, et al.
Circulation|May 6, 2015
Response to letter regarding article, "Proprotein convertase subtilisin kexin type 9 promotes intestinal overproduction of triglyceride-rich apolipoprotein B lipoproteins through both low-density lipoprotein receptor-dependent and -independent mechanisms"Shirya Rashid, Hagai Tavori, Patrick E Brown, et al.
Journal of Lipid Research|September 4, 2014
Macrophage-derived apoESendai suppresses atherosclerosis while causing lipoprotein glomerulopathy in hyperlipidemic miceHagai Tavori, Daping Fan, Ilaria Giunzioni, et al.
Circulation|July 30, 2014
Proprotein convertase subtilisin kexin type 9 promotes intestinal overproduction of triglyceride-rich apolipoprotein B lipoproteins through both low-density lipoprotein receptor-dependent and -independent mechanismsShirya Rashid, Hagai Tavori, Patrick E Brown, et al.
Circulation|May 26, 2018
Deletion of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Accelerates Atherosclerosis Regression and Increases C-C Chemokine Receptor Type 7 (CCR7) Expression in Plaque MacrophagesPaul A Mueller, Lin Zhu, Hagai Tavori, et al.
Circulation|April 16, 2019
Response by Mueller et al to Letter Regarding Article, "Deletion of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Accelerates Atherosclerosis Regression and Increases C-C Chemokine Receptor Type 7 (CCR7) Expression in Plaque Macrophages"Paul A Mueller, Lin Zhu, Hagai Tavori, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 2, 2016
Loss of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 Confers Resistance to the Antiatherogenic Effects of Tumor Necrosis Factor-α InhibitionLin Zhu, Ilaria Giunzioni, Hagai Tavori, et al.
Pageof 2